Puma Biotechnology Inc
NASDAQ:PBYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
|
Regions Financial Corp
NYSE:RF
|
US |
|
Azerion Group NV
AEX:AZRN
|
NL |
|
M
|
Mitsubishi Kakoki Kaisha Ltd
TSE:6331
|
JP |
|
E
|
EVN AG
VSE:EVN
|
AT |
|
A
|
Avance Gas Holding Ltd
F:A07
|
BM |
|
A
|
AutoCanada Inc
F:31K
|
CA |
|
Hera SpA
LSE:0NVV
|
IT |
|
Aker BP ASA
F:ARC
|
NO |
|
EVI Industries Inc
F:2YE
|
US |
|
T
|
Trinity Ltd
F:7TR
|
HK |
|
United Utilities Group PLC
LSE:UU
|
UK |
|
D
|
Domain Holdings Australia Ltd
OTC:DHGAF
|
AU |
|
China Coal Energy Co Ltd
HKEX:1898
|
CN |
|
HeidelbergCement AG
XETRA:HEI
|
DE |
|
S
|
SM Energy Co
F:SJL
|
US |
|
Puregold Price Club Inc
OTC:PGCMF
|
PH |
Wall St Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBYI's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Puma Biotechnology Inc?
Projected CAGR
-1%
The compound annual growth rate for Revenue over the next 5 years is -1%.
What is the Gross Profit forecast for Puma Biotechnology Inc?
Projected CAGR
-1%
The compound annual growth rate for Gross Profit over the next 5 years is -1%.
What is the Pre-Tax Income forecast for Puma Biotechnology Inc?
Projected CAGR
-42%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -42%.
What is the Net Income forecast for Puma Biotechnology Inc?
Projected CAGR
-25%
The compound annual growth rate for Net Income over the next 5 years is -25%.
